David Turkaly
Stock Analyst at JMP Securities
(2.09)
# 2,980
Out of 5,008 analysts
139
Total ratings
37.8%
Success rate
-4.63%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KIDS OrthoPediatrics | Maintains: Market Outperform | $50 → $35 | $18.24 | +91.89% | 11 | Aug 8, 2025 | |
| LNTH Lantheus Holdings | Maintains: Market Outperform | $112 → $73 | $52.70 | +38.52% | 9 | Aug 7, 2025 | |
| OFIX Orthofix Medical | Reiterates: Market Perform | n/a | $14.17 | - | 2 | Jun 6, 2025 | |
| GMED Globus Medical | Reiterates: Market Perform | n/a | $60.17 | - | 3 | May 27, 2025 | |
| HAE Haemonetics | Reiterates: Market Outperform | $100 | $49.55 | +101.82% | 12 | May 20, 2025 | |
| STE STERIS | Maintains: Market Outperform | $265 → $280 | $240.64 | +16.36% | 18 | May 16, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Market Outperform | $35 → $25 | $14.50 | +72.41% | 15 | May 9, 2025 | |
| ENOV Enovis | Maintains: Market Outperform | $62 → $55 | $31.26 | +75.94% | 2 | May 9, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Market Outperform | $140 → $125 | $98.83 | +26.48% | 14 | May 7, 2025 | |
| CRWD CrowdStrike Holdings | Maintains: Market Outperform | $400 → $500 | $495.95 | +0.82% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $366.28 | - | 3 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $127.71 | - | 15 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $12 → $7 | $1.52 | +362.05% | 6 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $26 | $17.16 | +51.52% | 7 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $32 | $14.49 | +120.84% | 7 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $16 | $8.52 | +87.79% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $2.89 | - | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $7 → $3 | $2.83 | +6.01% | 7 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $8.57 | -41.66% | 1 | Oct 6, 2017 |
OrthoPediatrics
Aug 8, 2025
Maintains: Market Outperform
Price Target: $50 → $35
Current: $18.24
Upside: +91.89%
Lantheus Holdings
Aug 7, 2025
Maintains: Market Outperform
Price Target: $112 → $73
Current: $52.70
Upside: +38.52%
Orthofix Medical
Jun 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $14.17
Upside: -
Globus Medical
May 27, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $60.17
Upside: -
Haemonetics
May 20, 2025
Reiterates: Market Outperform
Price Target: $100
Current: $49.55
Upside: +101.82%
STERIS
May 16, 2025
Maintains: Market Outperform
Price Target: $265 → $280
Current: $240.64
Upside: +16.36%
Integra LifeSciences Holdings
May 9, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $14.50
Upside: +72.41%
Enovis
May 9, 2025
Maintains: Market Outperform
Price Target: $62 → $55
Current: $31.26
Upside: +75.94%
Zimmer Biomet Holdings
May 7, 2025
Maintains: Market Outperform
Price Target: $140 → $125
Current: $98.83
Upside: +26.48%
CrowdStrike Holdings
May 5, 2025
Maintains: Market Outperform
Price Target: $400 → $500
Current: $495.95
Upside: +0.82%
May 5, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $366.28
Upside: -
Apr 2, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $127.71
Upside: -
Mar 21, 2025
Maintains: Market Outperform
Price Target: $12 → $7
Current: $1.52
Upside: +362.05%
Mar 5, 2025
Reiterates: Market Outperform
Price Target: $26
Current: $17.16
Upside: +51.52%
Feb 25, 2025
Reiterates: Market Outperform
Price Target: $32
Current: $14.49
Upside: +120.84%
Jan 29, 2025
Reiterates: Market Outperform
Price Target: $16
Current: $8.52
Upside: +87.79%
Sep 16, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $2.89
Upside: -
Aug 14, 2024
Maintains: Market Outperform
Price Target: $7 → $3
Current: $2.83
Upside: +6.01%
Oct 6, 2017
Initiates: Outperform
Price Target: $5
Current: $8.57
Upside: -41.66%